NAV
254.41(0.34%)Fund Size (CR)
₹1,096.95Expense Ratio
1.3Scheme Type
Active FundValue Research
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1Exit Load
1%Return Since Launch
16.27%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Kamal Gada
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 7 October 2025 | 10021.20 | 0.21% | - | -0.19% | 260/920 |
1 Month | 12 September 2025 | 9801.78 | -1.98% | - | -0.15% | 833/916 |
3 Month | 14 July 2025 | 9998.78 | -0.01% | - | 0.75% | 462/880 |
6 Month | 11 April 2025 | 11212.43 | 12.12% | - | 14.07% | 477/860 |
1 Year | 14 October 2024 | 10097.74 | 0.98% | 0.98% | -1.40% | 228/756 |
3 Year | 14 October 2022 | 19926.83 | 99.27% | 25.81% | 20.41% | 79/494 |
5 Year | 14 October 2020 | 23301.52 | 133.02% | 18.42% | 22.56% | 287/394 |
Since Inception | 1 January 2013 | 68783.10 | 587.83% | 16.27% | 13.35% | 356/920 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 4 November 2024 | 1,20,000 | 126101.01 | 5.08% | 5.08% |
3 Year | 1 November 2022 | 3,60,000 | 511062.07 | 41.96% | 12.39% |
5 Year | 2 November 2020 | 6,00,000 | 992776.56 | 65.46% | 10.60% |
10 Year | 2 November 2015 | 12,00,000 | 3126354.90 | 160.53% | 10.05% |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.52%
Standard Deviation
0.84%
Beta
1.22%
Sharpe Ratio
0.01%
Treynor's Ratio
14.93%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 9.61% | 661016 | 105.39 | Equity | Pharmaceuticals |
Cipla | 5.48% | 400000 | 60.13 | Equity | Pharmaceuticals |
Ajanta Pharma | 5.48% | 250000 | 60.16 | Equity | Pharmaceuticals |
Lupin | 4.70% | 270000 | 51.61 | Equity | Pharmaceuticals |
P & G Health Ltd | 3.99% | 69320 | 43.72 | Equity | Pharmaceuticals |
Dr Reddy's Labs | 3.74% | 335000 | 40.99 | Equity | Pharmaceuticals |
Glenmark Pharma. | 3.74% | 210000 | 41.01 | Equity | Pharmaceuticals |
Gland Pharma | 3.62% | 199297 | 39.69 | Equity | Pharmaceuticals |
Apollo Hospitals | 3.58% | 53000 | 39.27 | Equity | Healthcare |
Alkem Lab | 3.56% | 72000 | 39.06 | Equity | Pharmaceuticals |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
UTI-Healthcare Fund - Direct (IDCW) | 1096.95 | -1.98% | -0.01% | 12.12% | 0.98% | 25.81% | |
Nippon India Taiwan Equity Fund - Direct (G) | 406.67 | -1.43% | 22.60% | 80.49% | 39.76% | 40.29% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 406.67 | -1.43% | 22.60% | 80.49% | 39.76% | 40.29% | |
Aditya Birla SL International Equity Fund - Direct (G) | 266.19 | 1.03% | 10.15% | 28.72% | 27.38% | 20.99% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 266.19 | 1.03% | 10.15% | 28.72% | 27.38% | 20.99% | |
Nippon India Japan Equity Fund - Direct (G) | 289.73 | -1.74% | 10.07% | 20.06% | 15.36% | 19.65% |
List of Schemes under UTI Mutual Fund
News
UTI Mutual Fund Change in Minimum Application Amount
UTI Mutual Fund announces that the Minimum Application Amount for UTI Silver ETF Fund of Fund stands modified as under with effect from October 3, 2025UTI Silver ETF Fund of Fund
Existing Revised Minimum Application Amount / switch for Purchase Minimum initial investment amount is Rs.5,000/- and in multiples of Re.1/- thereafter. The minimum SIP amount for daily, weekly and Monthly, SIP is Rs.500/- and in multiples of Re.1/- thereafter.
Minimum initial investment amount is Rs.100/- and in multiples of Re.1/- thereafter. The minimum SIP amount for daily, weekly and Monthly, SIP is Rs.100/- and in multiples of Re.1/- thereafter.
Minimum Additional Purchase amount Subsequent minimum investment under a folio is Rs.1,000/- and in multiples of Re.1/- thereafter with no upper limit. Subsequent minimum investment under a folio is Rs.100/- and in multiples of Re.1/- thereafter with no upper limit. Minimum Redemption Amount The minimum Redemption amount is Rs.1,000/- and in multiples of Re.1/- thereafter. The minimum Redemption amount is Rs.100/- and in multiples of Re.1/- thereafter. Powered by Capital Market - Live News
UTI Mutual Fund announces change in Key Personnel
UTI Mutual Fund has announced the Mr. Chirag Sureka has been appointed as a Vice President & Head - Credit Research and Key Personnel of UTI Asset Management Private Limited With effect from 01 October 2025Details of Mr. Chirag Sureka
Age: 33 years
Designation: Vice President & Head - Credit Research
Qualification: MBA Finance from NMIMS, Mumbai
Chartered Financial Analyst (CFA) CharterholderPowered by Capital Market - Live News
UTI Mutual Fund announces change in fund manager under its scheme
UTI Mutual Fund has announced change in fund manager under the following scheme, With effect from 18 September 2025Change in Fund Manager:
Scheme Name Existing Fund Managers New Fund Manager UTI Banking & Financial Services Fund Ms Preethi R S
Mr. Amit PremchandaniMr. Amit Premchandani Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
1 January 2013
Total AUM (Cr)
₹1096.95
UTI-Healthcare Fund - Direct (IDCW) is an Sectoral / Thematic-oriented fund from the renowned AMC, UTI Mutual Fund. Launched in 1 January 2013, this fund is managed by Kamal Gada. With assets under management (AUM) worth ₹1,096.95 (Cr), as of 15 October 2025, UTI-Healthcare Fund - Direct (IDCW) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 16.27% since its launch.
The current NAV of UTI-Healthcare Fund - Direct (IDCW) is ₹254.41, as on 15 October 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in UTI-Healthcare Fund - Direct (IDCW) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment. The fund has generated 25.81% and 18.42% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.99% in Equity, 1.03% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 75.34% in Pharmaceuticals & Biotech, 23.54% in Healthcare Services, 0.64% in Cash & Others, 0.47% in Healthcare Equipment & Su, 0.01% in Others